Pharmaceuticals

Mumps Vaccine (MumpsVax) Market Forecast 2026–2035: Data Trends and Industry Insights

March 6, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the mumps vaccine (mumpsvax) market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Mumps Vaccine (MumpsVax) Market in 2026, and what figure is it projected to hit by 2030?

Historical growth during that period stemmed from the frequent occurrence of mumps outbreaks, the implementation of routine childhood immunization programs, the proven efficacy of live attenuated vaccines, governmental public health vaccination mandates, and the subsequent reduction in the disease burden following immunization.

The anticipated growth during the forecast period is propelled by the imperative to avert recurrent outbreaks, the reinforcement of school immunization policies, the expansion of worldwide vaccination coverage, a concentrated effort on sustaining herd immunity, and enhancements in public health surveillance.

Significant developments for the forecast period encompass ongoing demand for multi-component vaccines, a primary focus on childhood immunization initiatives, their persistent application in managing disease outbreaks, their incorporation into national immunization timetables, and an emphasis on achieving lasting population immunity.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19909&type=smp

Which Drivers Are Affecting Market Participation In The Mumps Vaccine (MumpsVax) Market?

The increasing occurrence of infectious diseases is anticipated to boost the mumps vaccine (mumpsvax) market moving forward. Infectious diseases are illnesses stemming from pathogenic microorganisms such as viruses, bacteria, fungi, or parasites, capable of spreading between individuals or via contaminated environments. The rise in these diseases is largely influenced by factors like urbanization, climate change, globalization, and shifts in human demographics and behavior, all of which facilitate pathogen transmission and emergence. Mumpsvax, a mumps vaccine, primarily prevents mumps infection, an infectious disease caused by the mumps virus, and is frequently included in the MMR (measles, mumps, rubella) vaccination. For instance, in August 2024, a report from the UK Health Security Agency, a UK-based government body, indicated that in 2023, the West Midlands region recorded the highest number of measles cases with 160 cases (44%), followed by London with 122 cases (33%). Notably, children under 10 years old accounted for 63% of the total cases, amounting to 232 cases. Measles activity escalated significantly towards the end of the year, with 157 new cases documented in December, compared to just 45 cases in November. Therefore, the growing prevalence of infectious diseases is a driving force for the mumps vaccine (mumpsvax) market. Increased healthcare expenditure is expected to propel the growth of the mumps vaccine (mumpsvax) market. Healthcare expenditure refers to the total funds allocated to health goods and services, including personal healthcare, preventive services, and public health initiatives, all aimed at improving health outcomes within a specified timeframe. The rise in healthcare expenditure is attributed to an aging population, the prevalence of chronic diseases, advanced medical technology, high drug prices, inefficient payment models, and an elevated demand for services. Greater healthcare spending impacts the mumps vaccine (mumpsvax) by increasing funding for vaccination programs, which can enhance access to the vaccine and lead to improved public health outcomes through higher immunization rates against mumps. For example, in May 2024, a report from the Office for National Statistics, a UK-based government agency, stated that total healthcare expenditure nominally increased by 5.6% from 2022 to 2023, contrasting with a 0.9% growth rate in 2022. Additionally, total long-term health and social care expenditure saw a real terms increase of 2.8% in 2022. Consequently, rising healthcare expenditure is a key driver for the mumps vaccine (mumpsvax) market.

What Segment Categories Are Covered In The Mumps Vaccine (MumpsVax) Market?

The mumps vaccine (mumpsvax) market covered in this report is segmented –

1) By Product Type: Monovalent, Combinational, Divalent, Trivalent, Other Product Types

2) By Age Group: Pediatric, Adult

3) By Distribution Channels: Hospital pharmacies, Drug Stores, Retail Pharmacies

4) By End-User: Pediatric Clinic, Hospitals, Non-Governmental Organization (NGOs), Other End-Users

Which Key Players Are Driving Competition In The Mumps Vaccine (MumpsVax) Market?

Major companies operating in the mumps vaccine (mumpsvax) market are Merck & Co. Inc., GlaxoSmithKline plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/mumps-vaccine-mumpsvax-global-market-report

Which Region Is Projected To Lead The Mumps Vaccine (MumpsVax) Market During The Forecast Period?

North America was the largest region in the mumps vaccine (mumpsvax) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mumps vaccine (mumpsvax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Mumps Vaccine (MumpsVax) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19909&type=smp

Browse Through More Reports Similar to the Global Mumps Vaccine (MumpsVax) Market 2026, By The Business Research Company

Chickenpox Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/chickenpox-vaccine-global-market-report

Protective Relays And Circuit Breakers Market Report 2026

https://www.thebusinessresearchcompany.com/report/protective-relays-and-circuit-breakers-global-market-report

Cervical Cancer Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/cervical-cancer-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795